Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA for Reduced Libido in Women Using Oral Contraceptives
NCT00566384Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2007
- Primary completion
- Apr 2009
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing DHEA + OC with Placebo + OC (2 arms). Primary endpoint: Female Sexual Function Index Desire and Arousal Domains at 24 weeks. Started Nov 2007; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00566384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566384.